Varian to start shipping LAST units
Varian Associates of Palo Alto, CA, plans to begin commercial shipments in June of its VIP-9-QR/1 digital fluoroscopy detector, which is based on the company's Large Area Sensing Technology (LAST) amorphous silicon digital detector. The company's Varian
Varian Associates of Palo Alto, CA, plans to begin commercial shipments in June of its VIP-9-QR/1 digital fluoroscopy detector, which is based on the company's Large Area Sensing Technology (LAST) amorphous silicon digital detector. The company's Varian Imaging Products subsidiary is supplying the detectors to OEMs for incorporation into complete fluoroscopy systems.
The VIP-9 detector is designed to replace image intensifier tubes in fluoroscopy systems. Image intensifiers are bulky and weigh up to 100 lb, which compares with a weight of about 15 lb for the Varian receptors. Picker International, for example, is using a Varian detector in its Venue interventional CT/x-ray suite to create more room for healthcare personnel working near patients (see story, page 3). In addition to fluoroscopy, VIP-9 supports digital radiography, and can also be used for nonmedical applications, such as nondestructive testing.
The VIP-9 detectors have not yet been cleared by the Food and Drug Administration and thus are limited to investigational use in medical applications. Varian will sell the detectors to OEMs at a list price of $98,000.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
